Author:
Burkey Jennifer L.,Campanale Kristina M.,Barbuch Robert,O'Bannon Douglas,Rash James,Benson Charles,Small David
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference23 articles.
1. Aiello LP, Vignoti L, Sheets MJ, Zhi E, Grach A, Dans MD, Milton RC, and the PKC-DRS2 Study Group (2005) The effect of the PKC-inhibitor ruboxistaurin on moderate visual loss: the PKC-DRS2 trial baseline characteristics and preliminary results. Presented at the American Academy of Ophthalmology Annual Meeting, Chicago, IL, October 14, 2005.
2. IN VIVO METABOLISM OF [14C]RUBOXISTAURIN IN DOGS, MICE, AND RATS FOLLOWING ORAL ADMINISTRATION AND THE STRUCTURE DETERMINATION OF ITS METABOLITES BY LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY AND NMR SPECTROSCOPY
3. Inhibition of Protein Kinase Cβ Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献